Erythrokeratodermia variabilis et progressiva
Alternate names[edit]
EKVP; Erythrokeratodermia variabilis; EKV; Erythrokeratodermia variabilis, Mendes da Costa type; Progressive symmetric erythrokeratodermia; PSEK; Erythrokeratodermia, progressive symmetric; Darier-Gottron disease; Progressiva symmetrica erythrokeratodermia; Erythrokeratoderma variabilis progressiva
Definition[edit]
Erythrokeratodermia variabilis et progressiva is a skin condition characterized by well-defined round or oval red scaly patches that may join together to form map-like patterns. Some patches are fixed, occurring most often on the outer surfaces of the arms and legs, while others are migratory - lasting for hours to days and then fading or moving to another location.
Epidemiology[edit]
EKVP is a rare disorder; its prevalence is unknown. More than 200 cases have been reported in the medical literature.
Cause[edit]
- EKVP can be caused by mutations in several genes, including GJB3, GJB4, and GJA1.
- These three genes provide instructions for making proteins called connexins 31, 30.3, and 43, respectively.
- These proteins are part of the connexin family, a group of proteins that form channels called gap junctions on the surface of cells.
- Gap junctions open and close to regulate the flow of nutrients, charged atoms (ions), and other signaling molecules from one cell to another.
- They are essential for direct communication between neighboring cells.
Gene mutations[edit]
- The GJB3, GJB4, and GJA1 gene mutations that lead to EKVP alter the structure or location of the connexins produced from these genes.
- Some GJB3 or GJB4 gene mutations lead to the production of abnormal connexins that can build up in a cell structure called the endoplasmic reticulum (ER), triggering a harmful process known as ER stress.
- Mutations in the GJA1 gene lead to the production of an abnormal connexin 43 protein that is unable to reach the cell surface to become part of gap junctions.
Inheritance[edit]
- EKVP is most often inherited in an autosomal dominant pattern.
- A few studies have shown that EKVP can also have an autosomal recessive pattern of inheritance.
Signs and symptoms[edit]
- This condition is characterized by well-defined round or oval red scaly patches that may join together to form map-like patterns.
- Some patches are fixed, occurring most often on the outer surfaces of the arms and legs, while others are migratory - lasting for hours to days and then fading or moving to another location.
- Some skin lesions are accompanied by burning or itching sensations.
- Common triggers include emotional stress, temperature changes, mechanical friction and hot or cold weather.
- Skin lesions often occur during the fist year of life, gradually progress during childhood, and then stabilize during puberty.
Diagnosis[edit]
Molecular Genetics Tests may include:
- Sequence analysis of the entire coding region
- Deletion/duplication analysis
- Targeted variant analysis
- Mutation scanning of the entire coding region
Treatment[edit]
Treatment is aimed at alleviating symptoms and may include topical retinoids or antihistamines.
| Diseases of ion channels | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
See also: ion channels
|
NIH genetic and rare disease info[edit]
Erythrokeratodermia variabilis et progressiva is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Erythrokeratodermia variabilis et progressiva
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
